Skip to main content
. 2017 Jul 20;7:5961. doi: 10.1038/s41598-017-05700-7

Table 2.

Tumour-to-organ ratios of 68Ga-DOTA-ZEGFR:2377 and 57Co-DOTA-ZEGFR:2377 after injection of 40 μg into BALB/C nu/nu mice bearing A431 xenografts.

3 h after injection 24 h after injection
68Ga-DOTA-ZEGFR:2377 57Co-DOTA-ZEGFR:2377 57Co-DOTA-ZEGFR:2377
Blood 7 ± 2a 12 ± 2 32 ± 7b
Salivary gland 7.3 ± 0.4a 10 ± 2 10.2 ± 0.8
Lung 5.9 ± 0.7a 10 ± 2 11 ± 1
Liver 0.44 ± 0.03a 3.1 ± 0.5 3.3 ± 0.3
Spleen 1.5 ± 0.4a 13.9 ± 0.7 11 ± 1b
Colon 7.1 ± 0.8a 10 ± 1 9 ± 1
Kidney 0.013 ± 0.002a 0.023 ± 0.002 0.019 ± 0.001b
Muscle 26 ± 3a 56 ± 10 48 ± 7
Bone 12 ± 2a 24 ± 5 21 ± 5

Data are average of four animals ± SD.

aSignificant (p < 0.05) difference between 68Ga-DOTA-ZEGFR:2377 and 57Co-DOTA-ZEGFR:2377.

bSignificant (p < 0.05) difference between values for 57Co-DOTA-ZEGFR:2377 at 3 and 24 h after injection.